Winton Group LTD Geron Corp Transaction History

Winton Group LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$1.2 - $1.5 $28,578 - $35,722	-23,815 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$1.25 - $1.83 $28,053 - $41,070	-22,443 Reduced 48.52%	23,815 $34,000
Q1 2021 Jul 21, 2021	BUY	$1.52 - $2.1 $25,452 - $35,164	16,745 Added 56.74%	46,258 $73,000
Q4 2020 Feb 12, 2021	SELL	$1.55 - $2.05 $63,678 - $84,220	-41,083 Reduced 58.19%	29,513 $47,000
Q3 2020 Oct 30, 2020	SELL	$1.59 - $2.19 $124,589 - $171,604	-78,358 Reduced 52.61%	70,596 $123,000
Q2 2020 Aug 05, 2020	BUY	$1.05 - $2.18 $156,401 - $324,719	148,954 New	148,954 $325,000
Q1 2020 May 11, 2020	SELL	$0.89 - $1.49 $107,655 - $180,231	-120,961 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.27 - $1.54 $153,620 - $186,279	120,961 New	120,961 $165,000
Q2 2019 Jul 08, 2019	SELL	$1.37 - $2.02 $30,524 - $45,007	-22,281 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$1.01 - $1.83 $22,503 - $40,774	22,281 New	22,281 $37,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.09B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.